biote (NASDAQ:BTMD) versus Field Trip Health (OTCMKTS:FTRPF) Head-To-Head Analysis

biote (NASDAQ:BTMD) and Field Trip Health (OTCMKTS:FTRPF) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for biote and Field Trip Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1	1	1	1	2.50
Field Trip Health	0	0	0	0	0.00

biote currently has a consensus price target of $2.50, suggesting a potential upside of 64.26%. Given biote’s stronger consensus rating and higher possible upside, equities analysts clearly believe biote is more favorable than Field Trip Health.

Profitability

This table compares biote and Field Trip Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
Field Trip Health	N/A	N/A	N/A

Earnings and Valuation

This table compares biote and Field Trip Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$192.22 million	0.28	$27.05 million	$0.11	13.84
Field Trip Health	N/A	N/A	N/A	N/A	N/A

biote has higher revenue and earnings than Field Trip Health.

Institutional and Insider Ownership

21.7% of biote shares are owned by institutional investors. 32.4% of biote shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

biote beats Field Trip Health on 9 of the 10 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Field Trip Health

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.